Skip to content
Monday, November 16, 2026
SmartCenter UK

Patients Discontinuing Weight-Loss Injections Gain Back Pounds Four Times Faster Than Dieters

Image of pharmaceutical injection and scale
Weight management involves long-term strategies.

Fresh analysis suggests that people who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop conventional lifestyle plans.

Findings released in a major medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing these medications need to be cognizant of the potential of fast rebound weight gain when the treatment ends," cautioned expert Dr. Susan Jebb.

This pace of recovery suggests a reversion to pre-treatment weight in about one and a half years.

Comparing Treatments

The analysis, which reviewed 37 of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.

The team point out that individuals who shed pounds through diet and exercise generally see a more gradual weight regain—approximately 100 grams monthly—after stopping.

Understanding the Quick Regain

Doctors believe the mechanism of the drugs is key to understanding the heightened weight return.

The injections mimic a body's own chemical called GLP-1, which controls hunger.

"Long-term administration of GLP-1 levels far above than normal might result in the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making excessive eating a significant risk."

A Lifelong Condition?

Health authorities suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Many experts say that, considering the significant potential of relapse, the therapy is often life-long.

This view is reinforced by drug manufacturers, who state that the results "highlight the chronic character of obesity," comparing it to managing diseases like high blood pressure.

User Testimonies

Users who have come off the jabs describe a intense return of hunger.

"It was like a trigger flipping and I was suddenly starving," recalled an individual.

This difficulty is compounded if users have not established sustainable lifestyle or habit changes during therapy.

Growing Use

Survey data suggest that a significant number of people in the UK have tried these injections in the past year, with interest remaining high.

  • Use is higher among females compared to males.
  • The 40s and 50s demographic shows the greatest usage rates.
  • Many access the medications through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a permanent fix and lasting health benefits hinges on integrated behavioural management.

ZM
Written by

Zachary Mckee

Elena Marsh is a tech enthusiast and smart home expert with over a decade of experience reviewing gadgets and home automation systems.

SmartCenter UK

Type to search articles.